Ribosome biogenesis controls cranial suture MSC fate via the complement pathway in mouse and human iPSC models
Stem Cell Reports · 2023
DOI: 10.1016/j.stemcr.2023.10.015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cell Reports, 2023. Verfasst von Supawadee Jariyasakulroj und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Craniofacial Molecular Biology, University of Southern California, Los Angeles, CA 90033, USA; Department of Masticatory Science, Faculty …. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Craniosynostoses. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, NHGRI NIH HHS, NIDCR NIH HHS.
Abstract (Originalsprache)
Disruption of global ribosome biogenesis selectively affects craniofacial tissues with unclear mechanisms. Craniosynostosis is a congenital craniofacial disorder characterized by premature fusion of cranial suture(s) with loss of suture mesenchymal stem cells (MSCs). Here we focused on ribosomopathy disease gene Snord118, which encodes a small nucleolar RNA (snoRNA), to genetically disturb ribosome biogenesis in suture MSCs using mouse and human induced pluripotent stem cell (iPSC) models. Snord118 depletion exhibited p53 activation, increased cell death, reduced proliferation, and premature osteogenic differentiation of MSCs, leading to suture growth and craniosynostosis defects. Mechanistically, Snord118 deficiency causes translational dysregulation of ribosomal proteins and downregulation of complement pathway genes. Further complement pathway disruption by knockout of complement C3a receptor 1 (C3ar1) exacerbated MSC and suture defects in mutant mice, whereas activating the complement pathway rescued MSC cell fate and suture growth defects. Thus, ribosome biogenesis controls MSC fate via the complement pathway to prevent craniosynostosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Craniofacial Molecular Biology, University of Southern California, Los Angeles, CA 90033, USA; Department of Masticatory Science, Faculty of Dentistry, Mahidol University, Bangkok 10400, Thailand.
- Center for Craniofacial Molecular Biology, University of Southern California, Los Angeles, CA 90033, USA.
- Department of Pharmacology and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA 90089, USA.
- Center for Craniofacial Molecular Biology, University of Southern California, Los Angeles, CA 90033, USA. Electronic address: jianfu@usc.edu.
Förderung
- NIA NIH HHS
- NHGRI NIH HHS
- NIDCR NIH HHS
- NIGMS NIH HHS
- National Institute of Dental and Craniofacial Research
- National Institutes of Health
- National Institute on Aging
Zitieren
APA
Jariyasakulroj, S., Zhang, W., Bai, J., Zhang, M., Lu, Z., & Chen, J. F. (2023). Ribosome biogenesis controls cranial suture MSC fate via the complement pathway in mouse and human iPSC models. Stem Cell Reports. https://doi.org/10.1016/j.stemcr.2023.10.015
Vancouver
Jariyasakulroj S, Zhang W, Bai J, Zhang M, Lu Z, Chen JF. Ribosome biogenesis controls cranial suture MSC fate via the complement pathway in mouse and human iPSC models. Stem Cell Reports. 2023. doi:10.1016/j.stemcr.2023.10.015
BibTeX
@article{Jariyasakulroj2023,
author = {Jariyasakulroj, Supawadee and Zhang, Wei and Bai, Jianhui and Zhang, Minjie and Lu, Zhipeng and Chen, Jian-Fu},
title = {Ribosome biogenesis controls cranial suture MSC fate via the complement pathway in mouse and human iPSC models},
journal = {Stem Cell Reports},
year = {2023},
doi = {10.1016/j.stemcr.2023.10.015}
}
EUVIMED